Discover free eBooks, guides and med spa templates on our new resources page
Explore our popular products
Centralised bookings and availability
Self-service booking, anytime
Consult notes drafted automatically
Secure access to bookings & payments
Custom clinical forms & notes
Secure in-clinic and online payments
Secure video consultations built in
Buy now, pay later is now available in Pabau
Elevate your care to the next level
Centralized client data & history
Automated SMS and email reminders
Flexible memberships & care plans
Reach goals with data-driven decisions
Secure treatment photo comparisons
Clear post-treatment care guidance
Fast clinical notes via dictation
Order and review labs in one place
Create & manage prescriptions easily
Premium patient care tools for smarter workflows and personalised experiences.
Schedule & collect payments with ease
Manage classes and attendance
Take payments at reception
Manage claims and reimbursements
Send quotes for approval
No-show, cancel, payment rules
Run your clinic on the go
Auto-fill cancelled slots
Manage your clinic with confidence
Group staff by roles
Track staff commissions easily
Track hours and attendance
Stay secure, efficient and compliant.
Clinic-wide performance reports
Real-time clinic metrics
Stock levels and suppliers
Pabau Insights Plus gives clinics real-time visibility into bookings, revenue, and practitioner performance, helping them make smarter decisions and grow efficiently.
Push your growth to the next level
Turn visitors into leads
Track and convert enquiries
Targeted email and SMS sends
Automated clinic processes
Reward repeat visits automatically
Sell vouchers upfront
Run diary-filling promotions
Collect reviews and feedback
Pabau Marketing Plus helps clinics attract, engage, and retain patients with built-in tools for workflows, campaigns, automations, and follow-ups, all connected directly to their booking and patient data.
Medical-led wellness and preventive care
Surgical and non-surgical aesthetic care
Specialist care for reproductive, hormonal, and sexual health
Non-surgical and regenerative care for movement and recovery
Clinical mental health and behavioral care
Read case studies from our satisfied clients
Compare Pabau with alternative systems
Learn why this holistic care and aesthetic medicine clinic chose Pabau to power patient care and performance.
Immunodeficiency with factor D anomaly, identified by ICD-11 code 4A00.13, is a rare primary immunodeficiency disorder. It stems from a deficiency or anomaly in Factor D, a crucial protein within the complement system's alternative pathway. The complement system is vital for innate immunity, aiding in the defence against infections and the clearance of cellular debris. A deficiency in Factor D impairs the proper functioning of this pathway, leading to an increased susceptibility to certain types of bacterial infections. This condition is a specific type of complement deficiency, impacting the body's ability to effectively combat pathogens.
Individuals with immunodeficiency with factor D anomaly often experience recurrent and potentially severe bacterial infections. The most commonly identified pathogens are encapsulated bacteria, particularly species of Neisseria, which can lead to serious conditions such as meningitis and sepsis. Infections caused by Haemophilus influenzae and Streptococcus pneumoniae are also frequently observed. While some individuals may remain asymptomatic for extended periods, the onset of a severe infection can be the first indication of the underlying deficiency. The increased susceptibility to these infections is a hallmark presentation of Factor D deficiency.
Immunodeficiency with factor D anomaly is primarily a genetic disorder, typically inherited. It arises from mutations in the Complement Factor D (CFD) gene. These genetic alterations lead to either a complete absence or a significant reduction in the functional levels of Factor D protein. The deficiency is often passed down through families, with reported cases involving homozygous or compound heterozygous variants in the CFD gene. While rare, understanding the genetic basis is key to identifying affected individuals and their family members.
Diagnosing immunodeficiency with factor D anomaly involves a combination of clinical assessment and laboratory testing. A history of recurrent, severe bacterial infections, especially those caused by Neisseria species, raises clinical suspicion. Laboratory investigations typically include functional complement assays, such as the AP50 test, which will show undetectable activity in individuals with complete Factor D deficiency. Specific measurement of Factor D protein levels, often using ELISA, confirms the deficiency. Genetic testing of the CFD gene can further validate the diagnosis by identifying specific mutations.
The management of immunodeficiency with factor D anomaly focuses on preventing and treating infections. Key strategies include comprehensive immunization schedules, particularly against encapsulated bacteria like Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae. Prompt and appropriate antibiotic treatment is crucial for any suspected or confirmed infection. In some cases, prophylactic antibiotic therapy may be considered to reduce the frequency of infections. While specific replacement therapies for Factor D are not standard, managing the underlying susceptibility through vaccination and timely medical intervention is paramount.
For accurate medical billing and record-keeping, the ICD-11 code 4A00.13 is used to classify 'Immunodeficiency with factor D anomaly'. This code falls under the broader category of primary immunodeficiencies and specifically denotes a defect in complement factor D. Common clinical synonyms include 'Factor D deficiency' and 'Complement factor D deficiency'. Precise documentation of the patient's history of recurrent infections, diagnostic test results (such as low AP50 activity or undetectable Factor D levels), and any genetic findings is essential for appropriate coding and clinical management. This specific ICD-11 code is reportable and billable when a diagnosis of Factor D anomaly is confirmed.
4.9 Trusted by 3,500+ healthcare practices worldwide
See how Pabau gives you all the tools you need to reduce admin, improve the patient experience, and support sustainable growth